相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Exploring death receptor pathways as selective targets in cancer therapy
Maria Russo et al.
BIOCHEMICAL PHARMACOLOGY (2010)
The BH3-mimetic GX15-070 induces autophagy, potentiates the cytotoxicity of carboplatin and 5-fluorouracil in esophageal carcinoma cells
Jingxuan Pan et al.
CANCER LETTERS (2010)
Mitochondria in cell death
Melissa J. Parsons et al.
ESSAYS IN BIOCHEMISTRY: MITOCHONDRIAL FUNCTION (2010)
The Bcl-2 Homology Domain 3 Mimetic Gossypol Induces Both Beclin 1-dependent and Beclin 1-independent Cytoprotective Autophagy in Cancer Cells
Ping Gao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
From sentencing to execution - the processes of apoptosis
Kelly L. Moffitt et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2010)
The Pan-Bcl-2 Inhibitor (-)-Gossypol Triggers Autophagic Cell Death in Malignant Glioma
Valerie Voss et al.
MOLECULAR CANCER RESEARCH (2010)
ABT-737 Overcomes Resistance to Immunotoxin-Mediated Apoptosis and Enhances the Delivery of Pseudomonas Exotoxin-Based Proteins to the Cell Cytosol
Roberta Traini et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Identification of Expression Signatures Predictive of Sensitivity to the Bcl-2 Family Member Inhibitor ABT-263 in Small Cell Lung Carcinoma and Leukemia/Lymphoma Cell Lines
Stephen K. Tahir et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Cancer-selective apoptotic effects of extracellular and intracellular Par-4
T. Shrestha-Bhattarai et al.
ONCOGENE (2010)
G3139 (Genasense) in Patients With Advanced Merkel Cell Carcinoma
Manisha H. Shah et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2009)
The Tumor Suppressor Par-4 Activates an Extrinsic Pathway for Apoptosis
Ravshan Burikhanov et al.
CELL (2009)
Bcl-2 inhibitors: small molecules with a big impact on cancer therapy
M. Vogler et al.
CELL DEATH AND DIFFERENTIATION (2009)
An Open-Label, Multicenter, Phase I/II Study of Single-Agent AT-101 in Men with Castrate-Resistant Prostate Cancer
Glenn Liu et al.
CLINICAL CANCER RESEARCH (2009)
Non-Peptidic Small Molecule Inhibitors Against Bcl-2 for Cancer Therapy
Asfar S. Azmi et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2009)
SMI of Bcl-2 TW-37 is active across a spectrum of B-cell tumors irrespective of their proliferative and differentiation status
Ayad M. Al-Katib et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)
ApoG2 induces cell cycle arrest of nasopharyngeal carcinoma cells by suppressing the c-Myc signaling pathway
Zhe-Yu Hu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2009)
Bim-targeted cancer therapy: A link between drug action and underlying molecular changes
Toru Akiyama et al.
MOLECULAR CANCER THERAPEUTICS (2009)
CXCR4 nuclear localization follows binding of its ligand SDF-1 and occurs in metastatic but not primary renal cell carcinoma
Linhui Wang et al.
ONCOLOGY REPORTS (2009)
sHA 14-1, a stable and ROS-free antagonist against anti-apoptotic Bcl-2 proteins, bypasses drug resistances and synergizes cancer therapies in human leukemia cell
Defeng Tian et al.
CANCER LETTERS (2008)
Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax)
Marina Konopleva et al.
CANCER RESEARCH (2008)
ABT-263: A potent and orally bioavailable Bcl-2 family inhibitor
Christin Tse et al.
CANCER RESEARCH (2008)
Alteration of the mitochondrial apoptotic pathway is key to acquired paclitaxel resistance and can be reversed by ABT-737
Ozgur Kutuk et al.
CANCER RESEARCH (2008)
A phase I pharmacokinetic and pharmacodynamic correlative study of the antisense Bcl-2 oligonucleotide G3139, in combination with carboplatin and paclitaxel, in patients with advanced solid tumors
Glenn Liu et al.
CLINICAL CANCER RESEARCH (2008)
Phase I/II Study of G3139 (Bcl-2 Antisense Oligonucleotide) in Combination with Doxorubicin and Docetaxel in Breast Cancer
Stacy L. Moulder et al.
CLINICAL CANCER RESEARCH (2008)
Targeting the extrinsic apoptosis pathway in cancer
Avi Ashkenazi
CYTOKINE & GROWTH FACTOR REVIEWS (2008)
被撤回的出版物: TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer(Retracted article. See vol.139,pg.2146,2016)
Zhiwei Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
ApoG2, a novel inhibitor of antiapoptotic Bcl-2 family proteins, induces apoptosis and suppresses tumor growth in nasopharyngeal carcinoma xenografts
Zhe-Yu Hu et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
ABT-737 Induces Expression of the Death Receptor 5 and Sensitizes Human Cancer Cells to TRAIL-induced Apoptosis
Jin H. Song et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Randomized phase II study of carboplatin and etoposide with or without the bcl-2 antisense oligonucleotide oblimersen for extensive-stage small-cell lung cancer:: CALGB 30103
Charles M. Rudin et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins
Cheol-Min Park et al.
JOURNAL OF MEDICINAL CHEMISTRY (2008)
Preclinical studies of apogossypolone:: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in follicular small cleaved cell lymphoma model
Alan A. Arnold et al.
MOLECULAR CANCER (2008)
Critical role of prostate apoptosis response-4 in determining the sensitivity of pancreatic cancer cells to small-molecule inhibitor-induced apoptosis
Asfar Sohail Azmi et al.
MOLECULAR CANCER THERAPEUTICS (2008)
ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo
Scott Ackler et al.
MOLECULAR CANCER THERAPEUTICS (2008)
BAD: undertaker by night, candyman by day
N. N. Danial
ONCOGENE (2008)
Noxa: at the tip of the balance between life and death
C. Ploner et al.
ONCOGENE (2008)
Bid: a Bax-like BH3 protein
L. P. Billen et al.
ONCOGENE (2008)
Apoptosis-based treatment of glioblastomas with ABT-737, a novel small molecule inhibitor of Bcl-2 family proteins
K. E. Tagscherer et al.
ONCOGENE (2008)
PUMA, a potent killer with or without p53
J. Yu et al.
ONCOGENE (2008)
BCL-2 dependence and ABT-737 sensitivity in acute lymphoblastic leukemia
Victoria Del Gaizo Moore et al.
BLOOD (2008)
The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin
James Witham et al.
CLINICAL CANCER RESEARCH (2007)
Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells
Ching-Huai Ko et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma
Suzanne Trudel et al.
BLOOD (2007)
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737
X. Lin et al.
ONCOGENE (2007)
NBK/BIK antagonizes MCL-1 and BCL-XL and activates BAK-mediated apoptosis in response to protein synthesis inhibition
Tsutomu Shimazu et al.
GENES & DEVELOPMENT (2007)
Preclinical studies of TW-37, a new nonpeptidic small-molecule inhibitor of Bcl-2, in diffuse large cell lymphoma xenograft model reveal drug action on both Bcl-2 and Mcl-1
Ramzi M. Mohammad et al.
CLINICAL CANCER RESEARCH (2007)
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing bak activation and bax translocation
Shuang Chen et al.
CANCER RESEARCH (2007)
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Victoria Del Gaizo Moore et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
Mark F. van Delft et al.
CANCER CELL (2006)
A stapled BID BH3 helix directly binds and activates BAX
Loren D. Walensky et al.
MOLECULAR CELL (2006)
Structure-based design of potent small-molecule inhibitors of anti-apoptotic Bcl-2 proteins
Guoping Wang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Antiangiogenic effect of TW37, a small-molecule inhibitor of Bcl-2
Benjamin D. Zeitlin et al.
CANCER RESEARCH (2006)
Mcl-1 interacts with truncated bid and inhibits its induction of cytochrome c release and its role in receptor-mediated apoptosis
JG Clohessy et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The small organic compound HA14-1 prevents Bcl-2 interaction with Bax to sensitize malignant glioma cells to induction of cell death
F Manero et al.
CANCER RESEARCH (2006)
Nuclear translocation of the pro-apoptotic Bcl-2 family member Bok induces apoptosis
G Bartholomeusz et al.
MOLECULAR CARCINOGENESIS (2006)
Characterization and quantification of Bcl-2 antisense G3139 and metabolites in plasma and urine by ion-pair reversed phase HPLC coupled with electrospray ion-trap mass spectrometry
GW Dai et al.
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2005)
Distinct mechanisms of neuronal apoptosis are triggered by antagonism of Bcl-2/Bcl-x(L) versus induction of the BH3-only protein Bim
AK Zimmermann et al.
JOURNAL OF NEUROCHEMISTRY (2005)
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
T Oltersdorf et al.
NATURE (2005)
Proapoptotic Bak is sequestered by Mcl-1 and Bcl-xL, but not Bcl-2, until displaced by BH3-only proteins
SN Willis et al.
GENES & DEVELOPMENT (2005)
Safety and biologic activity of intravenous BCL-2 antisense oligonucleotide (G3139) and taxane chemotherapy in patients with advanced cancer
MJ Morris et al.
APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY (2005)
Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix
LD Walensky et al.
SCIENCE (2004)
Discovery, characterization, and structure - Activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins
S Kitada et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
The Bcl-2 protein family: sensors and checkpoints for life-or-death decisions
C Borner
MOLECULAR IMMUNOLOGY (2003)
Three-dimensional structure of the apoptosome: Implications for assembly, procaspase-9 binding, and activation
D Acehan et al.
MOLECULAR CELL (2002)
Antimycin A mimics a cell-death-inducing Bcl-2 homology domain 3
SP Tzung et al.
NATURE CELL BIOLOGY (2001)
Apoptosis and cancer: Strategies for integrating programmed cell death
JC Reed
SEMINARS IN HEMATOLOGY (2000)
Exon skipping in Mcl-1 results in a Bcl-2 homology domain 3 only gene product that promotes cell death
CD Bingle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells
JL Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
